about
Drug-induced reactivation of apoptosis abrogates HIV-1 infectionThe complexities of epidemiology and prevention of gastrointestinal cancersTargeting translation initiation in breast cancerToward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniaeAntileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell LinesIron and cancer: more ore to be mined.Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteomeInhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity.Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathwayMaduramicin inhibits proliferation and induces apoptosis in myoblast cellsModulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer.Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cellsThe translation factor eIF5A and human cancer.Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cellsImmunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents.Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma.Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathwayCiclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.Isolation, Characterization and Bioactivities of an Extracellular Polysaccharide Produced from Streptomyces sp. MOE6.Anti-cancer iron(II) complexes of pentadentate N-donor ligands: cytotoxicity, transcriptomics analyses, and mechanisms of action.Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives.Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.Bioinformatics analysis reveals potential candidate drugs for cervical cancer.Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation.Myc, Oncogenic Protein Translation, and the Role of Polyamines.Utilizing ethacrynic acid and ciclopirox olamine in liver cancer
P2860
Q21090718-2FAA5B8C-1767-4193-9155-B55C5F0162EDQ26865429-6B125603-B9BE-4113-8E5E-C773B64D4CFCQ27027284-FF82D41D-5CD7-497C-8204-4EAD00C1325BQ28534775-A6E6377E-04B8-440F-BFFB-C1715203E494Q28553697-3CC1EE0C-FD33-4BF2-A46F-71749BDEF5B7Q33677592-93A0599A-CDDB-44E0-B89A-654A07DD558DQ33849693-DA6B1D98-404F-4CDB-B185-960CA5755C3AQ34035345-AC332B77-D8DA-4AE0-AC0B-2E7FEE7FF8D6Q34394153-14C09A8F-D3A5-4A16-86E7-2B86E862786FQ34654450-90494057-6974-4EE7-B26E-823268452DECQ35532104-A6F064B5-65B4-41B0-8D5B-4E0E56DDFEF2Q35670541-0A019E67-FE84-4EC0-A003-C06F4E885BAEQ35882208-2D0DC44C-6583-4CFB-AA67-5FABD46250EAQ36136572-23F868DE-B7C4-47DC-9D29-1842D267601EQ36519353-1B72DC84-00B9-436A-A398-FB832270BBCAQ36557053-E9D1B951-EF78-4608-B817-FB5DA616AACDQ37412018-8814245A-F6AC-4EA7-95C9-C2C836BA6ADFQ37991390-F04F7423-E19C-4BFA-86B1-3436E2B6C275Q38758962-D13B5F23-9051-4F19-81DF-B1ACF7BB3987Q38781000-71B52FD1-9BE0-4D54-A12E-7DCE6E7AA218Q38881007-B3605E49-A6FE-480C-A775-5BF0CFF848DEQ41195283-62A0EB18-963E-4EB9-9BD0-31749BFAC281Q41763423-6B9393F3-CE2B-4AD9-9A95-CF6956619CD8Q42872335-99FE7740-891F-4431-B60B-6C78B0B3CE58Q46316885-EFCEE55D-B72B-421B-889F-5D68E576C475Q46797115-5D5EDE6A-2CC9-4891-8A09-9E94D5D05AC8Q47112233-2EF9389B-47C3-4882-B37C-9F43A15555A3Q47854833-B13D1865-EE67-42DB-A44B-DE7C3B096002Q49385083-508B93E3-2D05-4C18-8238-80E842D1C109Q50067605-71C48520-FCFA-4D8D-9BB9-5EBD30B794A1Q50197358-00BEE929-1328-43D5-99E6-4F7E7B563003Q52657095-DF7FB2B7-2553-40AD-8757-2464CD7FC665Q54439891-52B78173-469F-4427-A585-280E6F595A3EQ54962976-8F42C5EB-6CD6-43C5-B924-B29CEF5E5E2AQ55414287-3E8FCF1C-A097-4529-BB76-6865B7348B67Q58571974-5D3F24B2-494E-4C8C-8C29-CFA757047E08
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The antitumor activity of the fungicide ciclopirox
@en
The antitumor activity of the fungicide ciclopirox.
@nl
type
label
The antitumor activity of the fungicide ciclopirox
@en
The antitumor activity of the fungicide ciclopirox.
@nl
prefLabel
The antitumor activity of the fungicide ciclopirox
@en
The antitumor activity of the fungicide ciclopirox.
@nl
P2093
P2860
P356
P1476
The antitumor activity of the fungicide ciclopirox
@en
P2093
Baoshan Xu
Chantal A Rivera
Hongyu Zhou
Wenxing Chen
Xiuzhen Han
P2860
P304
P356
10.1002/IJC.25255
P577
2010-11-01T00:00:00Z